ADR MONITORING CENTRE

REPORT ADR

Pharmacovigilance Awareness Program for Healthcare Professionals
@ Sri Lakshmi Narayana Institute of Medical Sciences, Puducherry.

Welcome All Healthcare professionals , Patients/Consumers

ADR MONITORING CENTRE at Department of Pharmacology, IGMC&RI was enrolled under National Coordination Centre-Pharmacovigilance Programme of India (NCC-PvPI), Indian Pharmacopoeia Commission, Ghaziabad since February 2013 and working hand –in –hand with Healthcare professionals tirelessly to ensure patient safety.

The Pharmacovigilance Programme of India (PvPI) was launched with a broad objective to safe guard the health of 1.27 billion people of India. Adverse drug Reactions (ADRs) are reported from all over the country to NCC-PvPI, which also work in collaboration with the global ADR monitoring centre (WHO-UMC), Sweden to contribute in the global ADRs data base. NCC-PvPI monitors the ADRs among Indian population and helps the regulatory authority of India (CDSCO) in taking decision for safe use of medicines.

Pharmacovigilance Glossary

Pharmacovigilance: According to World Health Organisation (WHO), Pharmacovigilance (PV) as the pharmacological science and activities relating to the monitoring, detection, assessment, understanding, and prevention of adverse drug reactions (ADRs), or any long-term and short term medicine-related problems.

Adverse Event: Medical occurrence temporally associated with the use of a medicinal product, but not necessarily causally related.

Adverse Drug Reaction (ADR): The World Health Organization (WHO) defines an ADR as “any response to a drug, which is noxious and unintended, and which occurs at doses used in man for prophylaxis, diagnosis, or therapy or for modification of physiologic function.” The definition excludes cases attributed to drug abuse or overdose (intended or unintended).